# A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults

> **NCT03549208** · PHASE1 · UNKNOWN · sponsor: **LG Chem** · enrollment: 60 (estimated)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **BIOLOGICAL:** LBVE01
- **BIOLOGICAL:** LBVE02
- **BIOLOGICAL:** Prevnar13

## Key facts

- **NCT ID:** NCT03549208
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-07-25
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549208, "A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03549208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*